GSA Capital Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,231
Closed -$392K 1802
2024
Q2
$392K Sell
8,231
-94
-1% -$4.48K 0.03% 1115
2024
Q1
$361K Sell
8,325
-3,355
-29% -$145K 0.03% 1098
2023
Q4
$591K Buy
+11,680
New +$591K 0.05% 685
2023
Q2
Sell
-9,422
Closed -$337K 1714
2023
Q1
$337K Buy
+9,422
New +$337K 0.03% 954
2022
Q3
Sell
-5,475
Closed -$203K 1690
2022
Q2
$203K Buy
+5,475
New +$203K 0.03% 1060
2022
Q1
Sell
-13,368
Closed -$407K 1602
2021
Q4
$407K Buy
+13,368
New +$407K 0.05% 731
2020
Q4
Sell
-15,842
Closed -$752K 1397
2020
Q3
$752K Buy
+15,842
New +$752K 0.13% 199
2020
Q1
Sell
-6,288
Closed -$380K 1291
2019
Q4
$380K Buy
+6,288
New +$380K 0.04% 847
2019
Q3
Sell
-19,690
Closed -$1.27M 1540
2019
Q2
$1.27M Buy
19,690
+4,590
+30% +$295K 0.14% 146
2019
Q1
$1.23M Sell
15,100
-2,800
-16% -$227K 0.12% 198
2018
Q4
$968K Buy
+17,900
New +$968K 0.11% 232
2018
Q3
Sell
-32,200
Closed -$1.34M 1758
2018
Q2
$1.34M Sell
32,200
-23,000
-42% -$959K 0.07% 543
2018
Q1
$2.43M Buy
55,200
+7,107
+15% +$313K 0.13% 189
2017
Q4
$2.42M Buy
48,093
+24,200
+101% +$1.22M 0.15% 157
2017
Q3
$1.21M Buy
23,893
+2,348
+11% +$119K 0.08% 393
2017
Q2
$1.1M Buy
+21,545
New +$1.1M 0.07% 489
2017
Q1
Sell
-11,141
Closed -$533K 1862
2016
Q4
$533K Buy
+11,141
New +$533K 0.03% 947
2015
Q4
Sell
-70,059
Closed -$2.83M 1879
2015
Q3
$2.83M Sell
70,059
-57,353
-45% -$2.32M 0.14% 134
2015
Q2
$7.33M Buy
127,412
+84,511
+197% +$4.86M 0.28% 27
2015
Q1
$2.73M Buy
42,901
+38,150
+803% +$2.43M 0.11% 192
2014
Q4
$293K Buy
+4,751
New +$293K 0.02% 1276
2014
Q3
Sell
-26,814
Closed -$924K 1818
2014
Q2
$924K Sell
26,814
-51,170
-66% -$1.76M 0.04% 729
2014
Q1
$3.37M Buy
77,984
+60,478
+345% +$2.61M 0.24% 76
2013
Q4
$697K Sell
17,506
-352
-2% -$14K 0.06% 579
2013
Q3
$670K Buy
+17,858
New +$670K 0.05% 593